mrtx1133 resistance - An Overview
That is an open up access report under the terms in the License, which permits use, distribution and replica in almost any medium, furnished the original operate is properly cited.In the trial involving 38 patients with Innovative pancreatic cancer, for instance, sotorasib shrank tumors in about twenty% of contributors. Comparable results have been